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Conclusions and perspectives 
The pathophysiology of neurodegenerative diseases 
is attributed to the death of specific neurons, for 
example the dopaminergic neurons in Parkinson’s 
Disease (PD). Mitochondrial dysfunction and 
excessive Reactive Oxygen Species (ROS) generation 
may play an important role in the development of 
PD. ROS is produced mostly due to the incomplete 
reduction of oxygen during oxidative 
phosphorylation. This process takes place in almost 
all cells as a side effect of respiratory ATP synthesis. 
In dopaminergic neurons, the problem of excessive 
ROS generation is aggravated because of the 
additional generation of ROS during ROS-induced 
dopamine degradation. The later is a chain reaction: 
ROS causes the degradation of dopamine, which in 
turn produces more ROS. 
Introduction Detailed network diagram 
 
A kinetic model of cellular ROS defence has been built. The model allows the 
simulation of the dynamic processes of the network related to PD pathologies 
resulting in the failure of cellular defence against excessive ROS generation.  
 
The model predicts a contradiction related to p62 upregulation, and we 
hypothesised here a compensatory function of p62 upregulation.  
 
The model will be improved and used for additional design principles studies of 
this regulatory network in the context of the development of PD.  
Figure 2. 39 species  and 45 reactions. Four different stages of the 
mitochondrion are considered: (i) functional; synthesising ATP and producing 
ROS, (ii) damaged; producing more ROS than ATP, (iii) low potential; producing 
small amounts of ROS and ATP, (iv) activated mitochondrial permeability 
transition pore (MPTP), producing only ROS and no ATP, and proceeding to 
high mitophagy.  
In human cells, a complicated regulatory network 
senses increased ROS concentration and counteracts 
this process, e.g. by activation of the synthesis of 
antioxidants or increasing the mitophagy (apoptosis 
of mitochondria). The precise “tuning” of the latter 
might be especially crucial: if mitophagy is too active, 
all mitochondria are lost and the cell dies from the 
lack of ATP; if mitophagy is not active enough, 
damaged mitochondria are accumulated, more ROS is 
produced, the cell is damaged further and finally dies.  
 
The development of the disease may be 
connected with the mistuning of the 
regulatory network. The expression of several 
components of the regulatory network 
(Figure 2) is altered in PD. We have collected 
data (Enrico Glaab, LCSB) on transcription 
levels of the following genes:  
 
1. KEAP1 (upregulated in PD vs. control) 
 
2. PINK1 (downregulated) 
 
3. PARK7 (downregulated)  
 
4. VDAC1 (downregulated) 
 
5. SQSTM1 (p62) (upregulated) 
 
We have built a kinetic model of the 
regulatory network based on the diagram of 
Figure 2. We perturbed the expression of the 
above genes in the model to simulate PD-
related misregulation of the network, which 
results in increased ROS generation and loss 
of mitochondria. 
 
Increasing KEAP1 in the model caused 
downregulation of p62 (SQSTM1). But our 
experimental observations have shown 
upregulation of p62 in PD. We formulate here 
the hypothesis that the upregulation of p62 is 
an adaptation to PD. 
              
Preliminary simulations with the kinetic model of cellular ROS defence 
Next, we introduce a step increase in the rate of ROS production (e.g. from 
degradation of dopamine) 
Under normal conditions (without PD-
related perturbations), the system can 
counteract the excessive ROS 
generation (black line). But if VDAC1 
and PARK7 are down-regulated (as in 
PD), then ROS reaches a higher steady 
state concentration (blue line).  
However, upregulation of p62 may 
counteract the down-regulation of 
VDAC1 and PARK7 (red line). 
On the other hand, downregulation of VDAC1 and PARK7 helps with the 
preservation of mitochondria and ATP. Simultaneous upregulation of p62 has 
almost identical effects on mitochondia and ATP preservation (while ROS 
concentration is decreased), therefore it is always advantageous! 
First, all five PD-related perturbations are applied at the same time. 
This results in excessive ROS generation and the loss of functional mitochondria: 
We then applied each perturbation individually. Below, the effect of KEAP1 
upregulation on ROS generation is displayed: 
Upregulation of p62 would be advantageous, as it would counteract the increase 
of KEAP1 and would reduce ROS generation: 
We hypothesize that the upregulation of p62 could be an adaptation to PD. 
Mechanisms for sensing ROS 
Simulating the disease 
But this also caused the decrease of p62. As stated above, experimental 
observations contradict this; p62 is upregulated in PD: 
